High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Nab-paclitaxel
Related studies linked through entity extraction aliases.
Nab-Pac+Cis+Gem in Pts w Previously Untreated Metastatic PDA
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Safety Study of Itacitinib (INCB039110) in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study to Evaluate Bi-weekly Dosing of Gemcitabine Plus Nab-Paclitaxel to Treat Metastatic Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE3
QUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
IST Neoadjuvant Abraxane in Newly Diagnosed Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer - Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase I/II NabPaclitaxel, Paclitaxel&Carboplatin w RTX Followed by Consolidation in Patients w Favorable Prognosis Inoperable Stage IIIA/B NSCLC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Schedules of Nab-Paclitaxel in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I-II Study of PAXG in Stage III-IV Pancreatic Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Single Arm on the Tolerability of Weekly Nab-paclitaxel
- Status
- COMPLETED
- Phase
- PHASE2
Study of Nab-Paclitaxel in High Risk Early Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Nab-Paclitaxel and Gemcitabine in Subjects With Previously Untreated Stage IV Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2